Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy

被引：55

作者：

Goetz, MB ^{[1
]}

Boscardin, WJ

Wiley, D

Alkasspooles, S

机构：

[1] VA Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA

[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA

[4] Univ Calif Los Angeles, Sch Nursing, Primary Care Sect, Los Angeles, CA 90024 USA

来源：

AIDS | 2001年 / 15卷 / 12期

关键词：

D O I：

10.1097/00002030-200108170-00017

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among virological responders, the area under the curve of the CD4 count minus baseline (AUCMB) after 3, 9, 15 and 18 months of highly active antiretroviral therapy (HAART) was less in individuals 55 years or older (P < 0.05). Fewer older individuals achieved increases of 50, 100, or over 150 CD4 cells/mul. A random quadratic time course model estimated that the AUCMB decreased 35 cells/year for each 10 years of additional age during the first 12 months after HAART (P < 0.005).

引用

页码：1576 / 1579

页数：4

共 17 条

[1]

[Anonymous], 2000, LANCET, V355, P1158

[2]

Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4

[3] Changes in thymic function with age and during the treatment of HIV infection [J].

Douek, DC ;

McFarland, RD ;

Keiser, PH ;

Gage, EA ;

Massey, JM ;

Haynes, BF ;

Polis, MA ;

Haase, AT ;

Feinberg, MB ;

Sullivan, JL ;

Jamieson, BD ;

Zack, JA ;

Picker, LJ ;

Koup, RA .

NATURE, 1998, 396 (6712) :690-695

[4] Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor [J].

Grabar, S ;

Pradier, C ;

Le Corfec, E ;

Lancar, R ;

Allavena, C ;

Bentata, M ;

Berlureau, P ;

Dupont, C ;

Fabbro-Peray, P ;

Poizot-Martin, I ;

Costagliola, D .

AIDS, 2000, 14 (02) :141-149

[5] Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study [J].

Greub, G ;

Ledergerber, B ;

Battegay, M ;

Grob, P ;

Perrin, L ;

Furrer, H ;

Burgisser, P ;

Erb, P ;

Boggian, K ;

Piffaretti, JC ;

Hirschel, B ;

Janin, P ;

Francioli, P ;

Flepp, M ;

Telenti, A .

LANCET, 2000, 356 (9244) :1800-1805

[6] The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection [J].

Haynes, BF ;

Markert, ML ;

Sempowski, GD ;

Patel, DD ;

Hale, LP .

ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :529-560

[7] Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter [J].

Kim, S ;

Hughes, MD ;

Hammer, SM ;

Jackson, JB ;

DeGruttola, V ;

Katzenstein, DA .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (07) :645-653

[8] Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].

Ledergerber, B ;

Egger, M ;

Opravil, M ;

Telenti, A ;

Hirschel, B ;

Battegay, M ;

Vernazza, P ;

Sudre, P ;

Flepp, M ;

Furrer, H ;

Francioli, P ;

Weber, R .

LANCET, 1999, 353 (9156) :863-868

[9] Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase [J].

Lederman, MM ;

McKinnis, R ;

Kelleher, D ;

Cutrell, A ;

Mellors, J ;

Neisler, M ;

Cooney, E ;

Haas, DW ;

Haubrich, R ;

Stanford, J ;

Horton, J ;

Landay, A ;

Spreen, W .

AIDS, 2000, 14 (17) :2635-2642

[10] Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease [J].

Li, TS ;

Tubiana, R ;

Katlama, C ;

Calvez, V ;

Ait Mohand, H ;

Autran, B .

LANCET, 1998, 351 (9117) :1682-1686

← 1 2 →